![Patrik Ringblom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrik Ringblom
Direktor/Vorstandsmitglied bei
SPECTRACURE AB
Profil
Patrik Ringblom is currently an Independent Director at SpectraCure AB since 2025 and Head-Strategy & US Lead at Lakefront Biotherapeutics since 2023.
Formerly, Mr. Ringblom was VP-Rare Disease Novel Therapeutics & Alliance at Johnson & Johnson from 2022 to 2023.
Mr. Ringblom completed an MBA at Handelshögskolan i Göteborg.
Aktive Positionen von Patrik Ringblom
| Unternehmen | Position | Beginn |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Corporate Officer/Principal | 01.10.2023 |
| SPECTRACURE AB | Direktor/Vorstandsmitglied | 01.01.2025 |
Ehemalige bekannte Positionen von Patrik Ringblom
| Unternehmen | Position | Ende |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.10.2023 |
Ausbildung von Patrik Ringblom
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
SpectraCure AB
 SpectraCure AB Electronic Equipment/InstrumentsElectronic Technology Develops and provides equipment for cancer treatment | Electronic Technology |
Handelshögskolan i Göteborg
 Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
